copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
dbGaP Study - National Center for Biotechnology Information N9741: Randomized phase III trial to compare the effectiveness of various combination chemotherapy regimens in treating patients who have advanced, recurrent, or metastatic colorectal cancer that cannot be treated with surgery or radiation therapy
National Center for Biotechnology Information The National Center for Biotechnology Information provides access to biomedical and genomic information, supporting research and discovery in life sciences
GEO Accession viewer NCBI's Gene Expression Omnibus (GEO) is a public archive and resource for gene expression data
Capecitabine Therapy and DPYD Genotype - National Center for . . . It is widely used in the treatment of colon cancer, metastatic colorectal cancer, and metastatic breast cancer Capecitabine is a prodrug that is enzymatically converted to its active form, fluorouracil, which acts as an antimetabolite to slow tumor growth
Preparing to download . . . Oxaliplatinum is derivate of platinum, which has been used for colorectal cancer since 1997 in France for first-line therapy of metastatic colorectal cancer Following the data from the MOSAIC trial (1), oxaliplatinum-based adjuvant therapy was established Development of the oxaliplatinum-based protocols lead to the development of FOLFOX4 (2) and FOLFOX6 (3) and subsequent FOLFOX7 protocols
Capecitabine response (Concept Id: CN077963) Capecitabine is a chemotherapeutic agent and a member of the fluoropyrimidine group of substances It is a prodrug of 5-fluorouracil and mainly used to treat solid tumors, such as colorectal, breast and aerodigestive cancers